Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. (Q49170807)
Jump to navigation
Jump to search
scientific article published in May 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. |
scientific article published in May 2005 |
Statements
1 reference
Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. (English)
1 reference
Kearon C
1 reference
Comp P
1 reference
Douketis J
1 reference
Royds R
1 reference
Yamada K
1 reference
Gent M
1 reference
1 May 2005
1 reference
3
1 reference
962-968
1 reference
5
1 reference
Identifiers
1 reference
1 reference